Not Yet RecruitingNot Applicable

Fungal Vascular Graft Infections, French Multicenter Retrospective Study

France300 participantsStarted 2026-01

Plain-language summary

Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Best therapeutic management is unknown. This study retrospectively gathers fungal VGEIs from 12 university hospital centers in France over a 10 year's period in order to describe their epidemiology, clinical features, therapeutic management and outcomes. Focusing on Candida spp. VGEIs, we aim to determine prognosis factors associated with therapeutic management

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged ≥ 18 years old with diagnosis of vascular graft and endograft infections (VGEI) in accordance to MAGIC criteria with diagnosis of proven invasive fungal infection according to EORTC criteria. * No opposition to re-use data. Exclusion Criteria: * Patient previously treated for fungal VGEI * Patient with suspected VGEI diagnosis based solely on prosthesis implantation in an infected site * Poor understanding of French. * Patient under legal protection.

What they're measuring

Rate of mortality

Timeframe: Year 1

Trial details

NCT IDNCT07143409

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-05

Contact for this trial

Mathilde Puges, MD

+335 56 79 55 36 mathilde.puges@u-bordeaux.fr

View on ClinicalTrials.gov More Fungal Infection trials